Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
<p>This is the protocol for a review and there is no abstract. The objectives are as follows:</p><p>To determine the efficacy and safety of anti-fibrinolytics (lysine analogues) in preventing bleeding in patients with haematological disorders.</p>
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Journal article |
| Publié: |
Cochrane Collaboration
2016
|